Skip to content
Vaytien123
  • About Us
  • Privacy
  • Sample Page
  • Home
  • Business

Industry expert interviews

Sun Pharma dips over 4% on weak margin growth expectation in FY25- Here’s what brokerages say

Business By admin · August 29, 2024 · Comments off

The shares of Sun Pharma plunged over 4% in the early trading session on Thursday, despite the company reporting a 34% jump in net profit year-on-year in Q4FY24 on Wednesday. The share price of Sun Pharma slipped 4.69% to an intra-day low of Rs 1,467 on the NSE.

Leading pharma player Sun Pharma reported a net profit of Rs 2,654 crore for the quarter ended March 2024 on Wednesday, ma…

Read more

Recent Posts

  • Larian boss Swen Vincke says subscription-based future could be "savage"
  • Respawn lays off staff, cancels another unannounced game
  • Nvidia Is Making It Easier To Use Game Pass On GeForce Now
  • Minecraft TV Show Coming To Netflix
  • All Abilities And Upgrades In Halo Infinite Campaign

Tags

Business performance metrics Business resilience strategies Business technology advancements Corporate social responsibility Economic impact of pandemics Economic policy analysis Financial technology developments Global supply chain issues Industry expert interviews Mergers and acquisitions Sustainability in business Workforce management news

Archives

  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • October 2024
  • September 2024
  • August 2024
  • Home
  • About Us
  • Privacy
  • Sitemap
Copyright © 2025 Vaytien123. All Right Reserved.